- Thinly traded nano cap Rosetta Genomics (ROSG-OLD +12.1%) heads north on more than a 21x surge in volume in apparent response a new composition of matter and method of use patent (U.S. No. 9,765,334) covering microRNA molecules associated with the prognosis of gastric cancer.